| 000 | 01847 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516022350.0 | ||
| 264 | 0 | _c20110616 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2011.01.022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHangalapura, Basav N | |
| 245 | 0 | 0 |
_aDelivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine. _h[electronic resource] |
| 260 |
_bVaccine _cMar 2011 |
||
| 300 |
_a2313-21 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigen-Presenting Cells _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCancer Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Priming |
| 650 | 0 | 4 |
_aDendritic Cells _ximmunology |
| 650 | 0 | 4 | _aInjections, Intradermal |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aLymph Nodes _ximmunology |
| 650 | 0 | 4 |
_aMelanoma, Experimental _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMyeloid Differentiation Factor 88 _xmetabolism |
| 700 | 1 | _aOosterhoff, Dinja | |
| 700 | 1 | _aGupta, Tarun | |
| 700 | 1 | _ade Groot, Jan | |
| 700 | 1 | _aWijnands, Pepijn G J T B | |
| 700 | 1 | _avan Beusechem, Victor W | |
| 700 | 1 | _aden Haan, Joke | |
| 700 | 1 | _aTüting, Thomas | |
| 700 | 1 | _avan den Eertwegh, Alfons J M | |
| 700 | 1 | _aCuriel, David T | |
| 700 | 1 | _aScheper, Rik J | |
| 700 | 1 | _ade Gruijl, Tanja D | |
| 773 | 0 |
_tVaccine _gvol. 29 _gno. 12 _gp. 2313-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2011.01.022 _zAvailable from publisher's website |
| 999 |
_c20552633 _d20552633 |
||